Hon. Harold “Hal” Rogers
U.S. Representative (KY-5th); Chair, U.S. House of Representatives Committee on Appropriations; and Co-Founder and Co-Chair, Congressional Caucus on Prescription Drug Abuse
Serving Kentucky’s 5th Congressional District since 1981, Congressman Rogers has a reputation of fighting for the interests of the region where he was raised. He helped launch multiple organizations to transform one of the poorest Congressional Districts in the nation, focusing on economic development, job creation, and preserving the natural treasures of southern and eastern Kentucky. He is the longest serving Kentucky Republican ever elected to federal office.
One of his greatest successes, Operation UNITE, earned the national spotlight through Rogers’ vision to combat the prescription drug abuse epidemic with a three-pronged approach, including law enforcement investigations, substance abuse treatment, and community education. In February 2013, Rogers received the Congressional Leadership Award from the Community Anti-Drug Coalitions of America (CADCA) for his unwavering commitment to keeping America’s youth drug and alcohol free.
Throughout his 33-year tenture in Congress, Rogers has served in a number of leadership roles, rising in 2011 to Chairman of the full House Committee on Appropriations. In his first year as Chairman, Rogers led the Congress to reduce discretionary spending by an historic amount and restored the culture on the Committee for serious budget oversight and transparency in process.
Nationally, Rogers is known as a titan in the war on drugs. Since 2000, Rogers has helped direct funding for marijuana eradication efforts of the Kentucky National Guard and the U.S. Forest Service in the Daniel Boone National Forest. In 2001, he established a competitive grant program within the Department of Justice to assist state-level Prescription Drug Monitoring Programs. Kentucky became the first state in the nation to provide a self-service, Internet-based system for tracking all schedule II-V prescription drugs.
As a long-time advocate for multi-tiered solutions to the ever-growing epidemic that has wreaked havoc on communities large and small, Rogers co-founded the Congressional Caucus on Prescription Drug Abuse with Congresswoman Mary Bono Mack. This caucus aims to unite like-minded policy-makers in raising awareness of abuse, while working toward innovative and effective policy solutions incorporating treatment, prevention, law enforcement and research.
Rogers holds a Bachelor of Arts degree from the University of Kentucky and Bachelor of Law degree from the University of Kentucky Law School.
Hon. Michael Grimm
U.S. Representative (NY-11th), Member, U.S. House Committee on Financial Services
At the age of 19, Michael left college and enlisted in the United States Marine Corps. After serving in the Persian Gulf War and being awarded a Combat Meritorious Promotion, he returned to reserve status and continued his education.
While attending college full time during the day, he went to work as a clerk for the FBI on the midnight shift. With a desire to diversify his background, he left the FBI for a Research Analyst position on Wall Street.
He later returned to the FBI where he served as a Special Agent and found his niche fighting corruption on Wall Street as a member of the Financial Fraud Squad.
During his service in the FBI, Michael attended New York Law School at night, graduating 9th in his class with high honors. After approximately 11 years as a Special Agent and more than 5 years serving as a deep Undercover Agent, he left the FBI and became an entrepreneur. Michael founded a small health food restaurant in Manhattan.
Michael Grimm was first elected to Congress in November 2010 and serves on the House Financial Services Committee. In the 112th Congress he was the Freshman Member with the most bills passed by the House of Representatives.
Hon. William R. “Bill” Keating
U.S. Representative (MA-9th), Member, U.S. House of Representatives, Member Homeland Security Committee, and Member, Foreign Affairs Committees
Congressman William R. “Bill” Keating was elected to the U.S. House of Representatives in 2010, one of only nine new Democratic Members to be elected to the 112th Congress. He represents Massachusetts’ 10th Congressional District, which encompasses the state’s South Shore, Cape Cod, Martha’s Vineyard and Nantucket.
Congressman Keating has already established himself as a hardworking civil servant and passionate advocate for the people of Massachusetts. His legislative priorities reflect a keen understanding of the issues facing his constituents and a commitment to addressing them.
He was asked to serve on three House Committees – Homeland Security, Small Business, and Foreign Affairs – a rare honor for a freshmen Member, and has already been assigned a ranking position on the Homeland Security’s Subcommittee on Oversight, Investigations and Management.
Prior to being elected to the U.S. House, Congressman Keating had already exemplified a life of public service and a commitment to the state of Massachusetts. He is the proud grandson of Irish immigrants and was instilled with the work ethic and principles inspired by them and his father, who was a police officer and then veterans’ service agent.
Congressman Keating received a BA and MA in business administration from Boston College. He was elected to the Massachusetts House in 1977. While serving in the House, he entered Suffolk University Law School and became a member of the state bar in 1985. The same year, he began serving in the Massachusetts State Senate, where he served as Senate Chairman of the Joint Committee on the Judiciary, the Joint Committee on Public Safety, and the Joint Committee on Taxation, respectively. He also served as the Senate Chairman of the standing Committee on Steering and Policy.
Congressman Keating was then elected to be Norfolk District Attorney, a position he held from 1999 until his election to Congress. As a District Attorney, he pursued some of Massachusetts’ toughest cases. He was instrumental in programs targeted to increase community-based crime prevention, prevent senior abuse, reduce incidents of domestic violence, provide post-traumatic stress disorder services for veterans, stop bullying in our schools and keep drugs off our streets.
Under his leadership, the Norfolk District Attorney’s office became the first in Massachusetts to win a murder conviction in a case that lacked a victim’s body. During this time, Bill also became one of the founding members of the Norfolk Advocates for Children, a public-private partnership whose mission is to aid abused children.
Hon. Daniel Webster
U.S. Representative (FL-10th), Member, U.S. House of Representatives Rules Committee
Congressman Webster, a family man and small-business owner, has dedicated himself to serving the citizens of Central Florida with honor and integrity. For nearly three decades, he has fought to advance common-sense reforms and principled policy.
Webster served as the Speaker of the Florida House and Majority Leader in the Senate, working in these leadership roles to shake up the status quo in Florida and pass sweeping reforms that earned him widespread praise from the people of Florida. From his first day in leadership, he worked to reform the way the Legislature did business, requiring all proposed laws to meet specific criteria that would determine their effectiveness in benefiting the people of the great state of Florida.
As the first non-lawyer to chair the Senate Judiciary Committee in Florida, Webster led Florida as the only state to pass a constitutional amendment protecting its citizens’ property rights in the aftermath of the landmark Kelo Case (2005) dealing with property rights and government’s ability to seize private property.
With his engineering background, Webster found transportation issues quite interesting and he was thrilled to serve as Ranking Member of the Transportation Committee in the Florida House representing Central Florida’s unique transportation needs. Currently, Webster is working in Congress on transportation issues to create jobs, improve Florida’s roads and highways, and find ways to save money by eliminating fraud and abuse.
Webster’s other committee assignment in Congress is on the influential House Rules Committee where he is fighting to bring more transparency to the process and advance a policy environment based on principle, not power.
R. Gil Kerlikowske
Director, White House Office of National Drug Control Policy (ONDCP)
Mr. Kerlikowske coordinates all aspects of federal drug control programs and implementation of the President’s National Drug Control Strategy. He brings 37 years of law enforcement and drug policy experience to the position. He most recently served 9 years as the Chief of Police for Seattle, Washington. When he left, crime was at its lowest point in 40 years. Previously, he was Deputy Director for the U.S. Department of Justice, Office of Community Oriented Policing Services, where he was responsible for over 6 billion dollars in Federal assets. Mr. Kerlikowske was also Police Commissioner of Buffalo, New York. The majority of his law enforcement career was in Florida where he served in the St. Petersburg Police Department.
He was elected twice to be President of the Major Cities Chiefs, which is comprised of the largest city and county law enforcement agencies in the United States and Canada, and was also elected President of the Police Executive Research Forum. He has received numerous awards and recognition for leadership, innovation, and community service. He served in the U.S. Army where he was awarded the Presidential Service Badge.
He served as the Chair of the Board of Directors of Fight Crime: Invest in Kids, a national organization that advocates for evidence-based programs that prevent youth from being involved in crime. He has also served on the advisory boards of the Salvation Army in Buffalo and Seattle.
Mr. Kerlikowske received the American Medical Association’s, Dr. Nathan Davis Award for Outstanding Government Service in 2011. He holds a B.A. and a M.A. in criminal justice as well as an Honorary Doctor in Humane Letters from the University of South Florida.
Hon. Michael R. Bloomberg
Mayor, City of New York
Michael R. Bloomberg is the 108th Mayor of the City of New York. He was first elected in November 2001, two months after the terrorist attacks of 9/11, a time when many believed that crime would return, businesses would flee, and New York might take decades to recover. Instead, through hundreds of innovative new policies and initiatives, Mayor Bloomberg has made New York City safer, stronger, and greener than ever.
Today, compared to 2001, crime is down by more than 30 percent. The welfare rolls are down nearly 25 percent. High school graduation rates are up more than 40 percent since 2005. Ambulance response times are at record lows. Teen smoking is down more than 50 percent. More than 730 acres of new parkland have been added. The Mayor’s economic policies have helped New York City avoid the level of job losses that many other cities experienced during the national recession. And since October 2009, New York has added as many private sector jobs as the next ten largest U.S. cities combined.
Mayor Bloomberg attended Johns Hopkins University, then went on to receive an MBA from Harvard Business School. In 1966 he was hired by a Wall Street firm, Salomon Brothers, for an entry-level job. He quickly rose through the ranks at Salomon, overseeing equity trading and sales before heading up the firm’s information systems. When Salomon was acquired in 1981, he was let go from the firm. With a vision of an information technology company that would bring transparency and efficiency to the buying and selling of financial securities, he launched a small startup company called Bloomberg LP. Today, Bloomberg LP is a global media company that has over 310,000 subscribers to its financial news and information service.
As his company grew, Michael Bloomberg started directing more of his attention to philanthropy, donating his time and resources to many different causes. He has sat on the boards of numerous charitable, cultural, and educational institutions, including The Johns Hopkins University, where, as chairman of the board, he helped build the Bloomberg School of Public Health into one of the world’s leading institutions of public health research and training.
During his three terms, Mayor Bloomberg has turned around a broken public school system by raising standards, promoting innovation, and holding schools accountable for success. He has spurred economic growth and job creation by revitalizing old industrial areas and strengthening key industries, including new media, film and television, bio-science, technology, and tourism. The Mayor’s Five Borough Economic Opportunity Plan has helped bring the City through the national recession as quickly as possible and helped avoid the level of job losses that many experts had forecast and that other cities experienced. He has also launched new, cutting-edge programs that encourage entrepreneurship, combat poverty, and help people acquire the skills they need to build careers.
His passion for public health has led to ambitious new health strategies that have become national models, including a ban on smoking in all indoor workplaces, as well as at parks and beaches. Today, life expectancy is 29 months longer than it was before Mayor Bloomberg took office. He has also created a far-reaching plan to fight climate change and promote sustainable development. His belief that America’s mayors and business leaders can help effect change in Washington led him to launch national bi-partisan coalitions to combat illegal guns, reform immigration, and invest in infrastructure. And he has been a strong champion of the City’s cultural community, expanding support for artists and arts organizations and helping to bring more than 85 permanent public art commissions to all five boroughs.
Dr. Margaret A. Hamburg, MD
Commissioner of Food and Drugs, U.S. Food and Drug Administration (FDA)
Dr. Hamburg became the 21st Commissioner of Food and Drugs on May 18, 2009. The second woman to be nominated for this position, she is an experienced medical doctor, scientist and public health executive. As the top official of the Food and Drug Administration (FDA), Dr. Hamburg is committed to strengthening programs and policies that enable the agency to carry out its mission to protect and promote the public health.
Dr. Hamburg graduated from Harvard Medical School and completed her residency in internal medicine at what is now New York–Presbyterian Hospital/Weill Cornell Medical Center. She conducted research on neuroscience at Rockefeller University, studied neuropharmacology at the National Institute of Mental Health, and later focused on AIDS research as assistant director of the National Institute of Allergy and Infectious Diseases.
From 2005-09, Dr. Hamburg was the senior scientist at the Nuclear Threat Initiative, a foundation dedicated to reducing the threat to public safety from nuclear, chemical and biological weapons. From 2001-05, as the foundation’s vice president for biological programs, she advocated for broad reforms to confront the dangers of modern bioterrorism as well as the threats of naturally occurring infectious diseases such as pandemic flu.
In 1997, Dr. Hamburg accepted the position of assistant secretary for policy and evaluation in the U.S. Department of Health and Human Services. In 1994, she was elected to the membership in the Institute of Medicine, one of the youngest persons to be so honored.
From 1991-97, Dr. Hamburg served as commissioner of the New York City Department of Health and Mental Hygiene. In this position, she improved services for women and children, promoted needle-exchange programs to reduce the spread of HIV, and initiated the nation’s first public health bioterrorism defense program. Her most celebrated achievement was curbing the spread of tuberculosis, which resurged as a major public health threat in the 1990s. As a result of Dr. Hamburg’s reforms, New York City’s TB rate fell significantly over a five-year span. Her innovative approach, which included sending health care workers to patients’ homes to make sure they completed the drug regimen, is now a model for health departments worldwide.
Dr. Thomas R. Frieden, MD, MPH
Director, Centers for Disease Control and Prevention (CDC) and
Prevention Administrator, Agency for Toxic Substances and Disease Registry (ATSDR)
Dr. Frieden became Director of the Centers for Disease Control and Prevention (CDC) and Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR) in June 2009. He has worked to control both communicable and noncommunicable diseases in the United States and around the world. From 1992-96, he led New York City’s program that rapidly controlled tuberculosis, including reducing cases of multidrug-resistant tuberculosis by 80 percent. He then worked in India for five years where he assisted with national tuberculosis control efforts. The program in India has treated more than 10 million patients and has saved more than one million lives.
As Commissioner of the New York City Health Department from 2002-09, he directed one of the world’s largest public health agencies, with an annual budget of $1.7 billion and more than 6,000 staff. During his tenure, the number of smokers declined by 350,000, teen smoking decreased by half, and New York City became the first place in the United States to eliminate trans-fats from restaurants, rigorously monitor the diabetes epidemic, and require certain restaurants to post calorie information prominently. The Department also greatly increased colon cancer screening and eliminated racial/ethnic disparities in colon cancer screening rates. Under Dr. Frieden’s leadership, the department also established the largest community electronic health records project in the country. The project provided prevention-oriented electronic health records to physicians caring for more than a million New Yorkers, including more than half of the doctors caring for patients in Harlem, the South Bronx, and Bedford-Stuyvesant. The project is a model for efforts to expand electronic health record use nationally.
Dr. Frieden also provided pro bono assistance to New York City Mayor Michael Bloomberg in his global health philanthropy; including helping to establish the Bloomberg Initiative to Reduce Tobacco Use, a strategic program which promotes the implementation of proven interventions which can save more than 100 million lives.
A physician with training in internal medicine, infectious diseases, public health and epidemiology, Dr. Frieden is especially known for his expertise in tuberculosis control. Dr. Frieden previously worked for CDC from 1990 until 2002. He began his career at CDC as an Epidemiologic Intelligence Service (EIS) Officer at the New York City Health Department.
Dr. Frieden speaks Spanish and graduated from Oberlin College. He received both his medical degree and master’s of public health degree from Columbia University and completed infectious disease training at Yale University. He has received numerous awards and honors and has published more than 200 scientific articles.
Dr. Nora D. Volkow, MD
Director, National Institute on Drug Abuse (NIDA)
Dr. Volkow became Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health in May 2003. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction. Her work has been instrumental in demonstrating that drug addiction is a disease of the human brain. As a research psychiatrist and scientist, Dr. Volkow pioneered the use of brain imaging to investigate the toxic effects and addictive properties of abusable drugs. Her studies have documented changes in the dopamine system affecting, among others, the functions of frontal brain regions involved with motivation, drive, and pleasure in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging.
Dr. Volkow was born in Mexico, attended the Modern American School, and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned the Laughlin Fellowship Award as one of the 10 Outstanding Psychiatric Residents in the USA.
Dr. Volkow spent most of her professional career at the Department of Energy’s Brookhaven National Laboratory (BNL) in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Director for Life Sciences. In addition, Dr. Volkow was a Professor in the Department of Psychiatry and Associate Dean of the Medical School at the State University of New York (SUNY)-Stony Brook.
Dr. Volkow has published more than 530 peer-reviewed articles, written more than 80 book chapters and non-peer reviewed manuscripts, and has also edited three books on neuroimaging for mental and addictive disorders.
During her professional career, Dr. Volkow has been the recipient of multiple awards, including her selection for membership in the Institute of Medicine in the National Academy of Sciences and the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science. She was recently named one of Time Magazine’s “Top 100 People Who Shape Our World” and was included as one of the 20 people to watch by Newsweek magazine in its “Who’s Next in 2007” feature. She was also included in Washingtonian Magazine’s 2009 and 2011 list of the “100 Most Powerful Women” and named “Innovator of the Year” by U.S. News & World Report in 2000.
Frances M. Harding
Director, Center for Substance Abuse Prevention (CSAP)
Ms. Harding serves as Director of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention (CSAP), and is recognized as one of the nation’s leading experts in the field of alcohol and drug policy. CSAP provides national leadership in the federal effort to prevent alcohol, tobacco and drug problems. As part of an Executive Leadership Exchange in SAMHSA, Ms. Harding served as Director of SAMHSA’s Center for Mental Health Services (CMHS) from July 2010-January 2011. CMHS leads federal efforts to treat mental illnesses by promoting mental health and by preventing the development or worsening of mental illness when possible.
Ms. Harding serves as the lead for SAMHSA’s Strategic Initiative on Prevention of Substance Abuse and Mental Illness, which creates communities where individuals, families, schools, faith-based organizations and workplaces take action to promote emotional health and reduce the likelihood of mental illness, substance abuse including tobacco, and suicide.
Prior to federal service, Ms. Harding served as Associate Commissioner of the Division of Prevention and Recovery at the New York State Office of Alcoholism and Substance Abuse Services, where she was responsible for the development of policy and guidelines for alcohol and drug abuse and gambling prevention, treatment, and recovery programming.
Ms. Harding has held numerous national positions, including serving as president of the National Prevention Network, an organization representing the alcohol and drug abuse prevention offices in all 50 states, and as New York State’s representative to the Board of Directors for the National Association of State Alcohol and Drug Abuse Directors. In 2004, she became the first non-researcher to receive the prestigious Science to Practice Award from the International Society for Prevention Research.
Joseph T. Rannazzisi, JD, RPH
Deputy Assistant Administrator, Office of Diversion Control, U.S. Drug Enforcement Administration (DEA)
Mr. Rannazzisi is responsible for overseeing and coordinating major pharmaceutical, precursor chemical, clandestine laboratory and synthetic drug investigations; the drafting and promulgating of regulations; establishing drug production quotas; and serves as liaison to the pharmaceutical industry, international governments, state governments, federal agencies and law enforcement agencies.
Mr. Rannazzisi began his career with the U.S. Drug Enforcement Administration (DEA) in 1986. He is a career Special Agent who held positions that include clandestine lab coordinator, Task Force Group Supervisor (Detroit Field Office), Assistant Special Agent in Charge (Detroit Field Division), Section Chief (Dangerous Drugs and Chemical Section), and Deputy Chief (Enforcement Operations). He was appointed to the position of Deputy Assistant Administrator for the Office of Diversion Control in January 2006.
Mr. Rannazzisi holds a bachelor of science degree in pharmacy from Butler University and a Juris Doctor degree from the Detroit College of Law at Michigan State University. He is a Registered Pharmacist in the state of Indiana and a member of the Michigan State Bar Association.
Hon. Pam Bondi
Attorney General, State of Florida
Pam Bondi has served as Florida’s 37th Attorney General since January 2011. A native of Tampa, AG Bondi is focused on protecting Floridians and upholding Florida’s laws and the Constitution. Since taking office, AG Bondi aggressively defended Florida’s rights against the federal health care law; was involved in the landmark $25 billion joint federal-state agreement with the nation’s five largest mortgage services over foreclosure abuses and unacceptable nationwide mortgage service practices; strengthened penalties to stop pill mills; and, address the problem of newborns exposed to the prescription drugs their mothers abused.
Under AG Bondi’s leadership, Florida has made great strides in fighting the Rx drug abuse problem. When she took office, approximately seven people were dying every day as a result of prescription drug overdoses. She has worked to rid the state of the pill mills that were once a primary source for Rx drug diversion in the Eastern United States. Within two years after making it one of her priorities, Florida saw a decrease in Rx drug deaths for the first time in nearly a decade.
It was during her work on the Rx drug abuse problem that AG Bondi learned of a new issue confronting the state. Pregnant women addicted to Rx drugs were giving birth to babies exposed to the drugs their mothers were abusing. These newborns were beginning life suffering from Neonatal Abstinence Syndrome.
Working with the Florida Legislature, AG Bondi created the Statewide Task Force on Prescription Drug Abuse and Newborns. The Task Force examined the scope of the problem in Florida, the costs associated with caring for babies with Neonatal Abstinence Syndrome, the long-term effects of the Syndrome, and strategies for preventing Rx drug abuse by expectant mothers. Earlier this year, the Task Force submitted a list of recommendations for dealing with the problem to the Legislature. AG Bondi believes the work of the Task Force could serve as a model for the rest of the nation.
For her work on the Rx drug abuse problem, AG Bondi received the National Association of Drug Diversion Investigators’ 2011 Leadership Award, and was awarded a special recognition award by the Florida Police Chiefs Association for her efforts to reduce Rx drug abuse and strengthen Florida’s Prescription Drug Monitoring Program through additional legislation via the “pill mill” bill. Additionally, AG Bondi was awarded the Florida Board of Medicine Chairman’s Recognition Award for her dedication and service to the people of Florida for her efforts to fight Rx drug abuse.
AG Bondi is dedicated to serving her community, including her membership on the Board of The Spring, Tampa’s domestic violence shelter. In her role as Attorney General, she serves on the Special Olympics Florida Board of Directors and is proud to promote their mission of assisting people with disabilities with being productive and respected members of our communities.
AG Bondi was awarded the Distinguished Alumna Award in 2011 by Stetson University for extraordinary service to Stetson Law and to the legal profession. During her career as a prosecutor, she was awarded the Lawyers of Distinction Award by the Tampa Bay Review for outstanding performance. She is a graduate of the University of Florida and Stetson Law School and has served as a prosecutor for more than 18 years. As an Assistant State Attorney for the 13th Judicial District, her investigative and courtroom experience includes the successful prosecution of numerous first-degree murder cases and two capital cases.